Yuan, Shuofeng
Yin, Xin http://orcid.org/0000-0003-2357-6718
Meng, Xiangzhi
Chan, Jasper Fuk-Woo http://orcid.org/0000-0001-6336-6657
Ye, Zi-Wei
Riva, Laura
Pache, Lars http://orcid.org/0000-0002-4193-1042
Chan, Chris Chun-Yiu
Lai, Pok-Man http://orcid.org/0000-0002-7967-8126
Chan, Chris Chung-Sing
Poon, Vincent Kwok-Man
Lee, Andrew Chak-Yiu http://orcid.org/0000-0002-8432-3282
Matsunaga, Naoko
Pu, Yuan http://orcid.org/0000-0002-7049-8452
Yuen, Chun-Kit
Cao, Jianli
Liang, Ronghui
Tang, Kaiming
Sheng, Li http://orcid.org/0000-0002-3139-8045
Du, Yushen http://orcid.org/0000-0002-8015-4207
Xu, Wan
Lau, Chit-Ying
Sit, Ko-Yung http://orcid.org/0000-0001-6289-663X
Au, Wing-Kuk http://orcid.org/0000-0002-6196-7317
Wang, Runming http://orcid.org/0000-0001-8525-5659
Zhang, Yu-Yuan
Tang, Yan-Dong
Clausen, Thomas Mandel
Pihl, Jessica
Oh, Juntaek
Sze, Kong-Hung
Zhang, Anna Jinxia http://orcid.org/0000-0002-5087-3614
Chu, Hin
Kok, Kin-Hang http://orcid.org/0000-0003-3426-332X
Wang, Dong http://orcid.org/0000-0002-2829-1546
Cai, Xue-Hui
Esko, Jeffrey D.
Hung, Ivan Fan-Ngai
Li, Ronald Adolphus
Chen, Honglin http://orcid.org/0000-0001-5108-8338
Sun, Hongzhe http://orcid.org/0000-0001-6697-6899
Jin, Dong-Yan http://orcid.org/0000-0002-2778-3530
Sun, Ren
Chanda, Sumit K. http://orcid.org/0000-0001-9399-7927
Yuen, Kwok-Yung http://orcid.org/0000-0002-2083-1552
Article History
Received: 30 September 2020
Accepted: 8 March 2021
First Online: 16 March 2021
Competing interests
: J.F.-W.C. has received travel grants from Pfizer Corporation Hong Kong and Astellas Pharma Hong Kong Corporation Limited, and was an invited speaker for Gilead Sciences Hong Kong Limited and Luminex Corporation. S.K.C. is an inventor on a patent application on repurposed antiviral compounds for SARS-CoV-2 owned by Scripps Research and Sanford Burnham Prebys. US Patent Application Serial No. 63/010630, entitled ‘Methods and Compositions for Antiviral Treatment’ relates to aspects of this work and was filed on 15 April 2020. The corresponding authors had full access to all the data in the study and had final responsibility for the decision to submit for publication. The other authors declare no competing interests.
Free to read: This content has been made available to all.